Scarica l'app Stockscreener
73.80
1.04%
0.76
Pre-mercato:
73.56
-0.24
-0.33%
Precedente Chiudi:
$73.04
Aprire:
$72.77
Volume 24 ore:
707.76K
Relative Volume:
0.84
Capitalizzazione di mercato:
$4.05B
Reddito:
$1.39B
Utile/perdita netta:
$-242.49M
Rapporto P/E:
-16.49
EPS:
-4.4759
Flusso di cassa netto:
$173.29M
1 W Prestazione:
-0.04%
1M Prestazione:
+25.25%
6M Prestazione:
+15.66%
1 anno Prestazione:
+70.95%
Intervallo 1D:
$72.46
$74.25
Intervallo di 1 settimana:
$70.74
$75.81
Portata 52W:
$41.02
$75.81
Livanova Plc Stock (LIVN) Company Profile
Nome
Livanova Plc
Settore
Industria
Telefono
4402033250662
Indirizzo
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
73.80 | 4.01B | 1.39B | -242.49M | 173.29M | -4.4759 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-19 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | Downgrade | Goldman | Buy → Neutral |
| 2025-05-20 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Iniziato | Goldman | Buy |
| 2024-09-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Reiterato | Needham | Buy |
| 2024-02-20 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-09-06 | Iniziato | HSBC Securities | Hold |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-04-14 | Iniziato | Mizuho | Neutral |
| 2022-12-21 | Iniziato | Barclays | Equal Weight |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-02-24 | Aggiornamento | UBS | Neutral → Buy |
| 2021-12-03 | Iniziato | Goldman | Buy |
| 2021-08-20 | Reiterato | Needham | Buy |
| 2021-07-20 | Aggiornamento | Needham | Hold → Buy |
| 2021-03-03 | Downgrade | Berenberg | Buy → Hold |
| 2021-01-05 | Downgrade | Needham | Buy → Hold |
| 2020-09-02 | Iniziato | Robert W. Baird | Outperform |
| 2020-06-26 | Reiterato | Needham | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-06-08 | Iniziato | Stifel | Buy |
| 2018-05-31 | Reiterato | Needham | Buy |
| 2018-02-28 | Reiterato | Needham | Buy |
Mostra tutto
Livanova Plc Borsa (LIVN) Ultime notizie
Did LivaNova's (LIVN) New Cardiopulmonary Chief from Philips Just Redefine Its Leadership Bench? - simplywall.st
Insider Sell Alert: Francesco Bianchi Sells Shares of LivaNova P - GuruFocus
LivaNova appoints Stefano Folli to lead its cardiopulmonary business unit - MSN
LivaNova Plc Hits New 52-Week High at USD 74.28 - Markets Mojo
LivaNova names Stefano Folli as president, CP - Medical Buyer
Why (LIVN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
LIVN Technical Analysis & Stock Price Forecast - Intellectia AI
LivaNova (LIVN) Edges Higher as Stock Tests Key Resistance at $77.52Dark Pool Prints - Newser
Paradice Investment Management LLC's LivaNova PLC(LIVN) Holding History - GuruFocus
LivaNova names Stefano Folli as cardiopulmonary president - Investing.com UK
LivaNova appoints Franco Poletti as President, Cardiopulmonary - TipRanks
LivaNova names Stefano Folli as cardiopulmonary president By Investing.com - Investing.com South Africa
LivaNova names Stefano Folli to head cardiopulmonary unit - StreetInsider
LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit - Business Wire
LivaNova PLC Lifts 2026 Outlook After Strong Q1 - The Globe and Mail
LivaNova PLC stock (US5356991077): cardiac device specialist in focus after regulatory update and ea - AD HOC NEWS
LivaNova’s SWOT analysis: medical device stock eyes growth plan By Investing.com - Investing.com Nigeria
LivaNova’s SWOT analysis: medical device stock eyes growth plan - Investing.com
LivaNova stock hits 52-week high at 73.31 USD By Investing.com - Investing.com Australia
LivaNova stock hits 52-week high at 73.31 USD - Investing.com
LivaNova to present at Goldman Sachs Global Healthcare Conference in June - MSN
LivaNova to Present at Goldman Sachs Global Healthcare Conference in June 2026 - BioSpace
LivaNova to Present at Goldman Sachs Global Healthcare Conference in June - Business Wire
Will LivaNova's (LIVN) Return to Quarterly Profitability Reset Investor Expectations on Its Turnaround Narrative? - simplywall.st
LivaNova PLC stock (US5356991077): cardiac device maker updates investors after latest earnings - AD HOC NEWS
Total debt per share of LivaNova Plc – SWB:LIA - TradingView
LivaNova PLCOrdinary Shares (NQ: LIVN - FinancialContent
Vagus Nerve Stimulators Market to Reach USD 1.86 Billion by 2033 - openPR.com
ETFs Investing in LivaNova Plc Stocks - TradingView
LivaNova stock (US5356991077): Medical device leader with Nasdaq listing - AD HOC NEWS
Understanding Momentum Shifts in (LIVN) - Stock Traders Daily
LivaNova (LIVN) Q3 2025 Earnings Transcript - AOL.com
LivaNova (LIVN) Stock Forum and Discussion - Moomoo
Drug Resistant Epilepsy Market to Reach US$ 1.28 Billion by 2033 - openPR.com
LivaNova stock hits 52-week high at 71.97 USD By Investing.com - Investing.com Nigeria
LivaNova PLC Lifts Guidance After Strong Q1 Call - TipRanks
LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Why LivaNova (LIVN) Is Up 18.0% After Boosting 2026 Outlook And Winning Aura6000 FDA Approval - Yahoo Finance
LivaNova stock hits 52-week high at 71.97 USD - Investing.com India
LivaNova PLC 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LIVN) 2026-05-08 - Seeking Alpha
LivaNova PLC (LIVN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Active Implantable Medical Devices Market Size is Anticipated - openPR.com
LIVN Maintained by Baird -- Price Target Lowered to $76.00 - GuruFocus
LIVN Maintained by Mizuho -- Price Target Raised to $90.00 - GuruFocus
Livanova Plc Azioni (LIVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.59%
1.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):